FDA approval for the drug seems likely, although investors should be wary that on average only ... Cas9 gene editing to be ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...

Part 2 is investigating the efficacy and safety of this three-drug combination in an expanded population of patients with RRMM ... Product Development of Oncology Solid Tumors at Genentech, a member ...